OverviewSuggest Edit

RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company's initial products under development target the body’s largest organ, the skin. The Company's flagship technology, the CellMist System, uses our patented SkinGun to spray a liquid suspension of a patient’s stem cells – the CellMist Solution – onto wounds. RenovaCare, Inc. is also developing medical-grade liquid spray devices for wound care and irrigation fluids.

TypePublic
HQNew York, US
Websiterenovacareinc.com

Latest Updates

Employees (est.) (Dec 2018)1
Revenue (FY, 2012)$19.5 K(-40%)
Share Price (Jul 2020)$2.2 (-4%)
Cybersecurity ratingAMore

Key People/Management at RenovaCare

Harmel S. Rayat

Harmel S. Rayat

Chairman of the Board of Directors
Kenneth Kirkland

Kenneth Kirkland

Director
Alan L. Rubino

Alan L. Rubino

President & Chief Executive Officer, Director
Robin A. Robinson

Robin A. Robinson

Chief Scientific Officer
Jo Ellen Schweinle

Jo Ellen Schweinle

Chief Medical Officer
Ben Walthall

Ben Walthall

Associate VP, Regenerative Technologies
Show more

RenovaCare Office Locations

RenovaCare has offices in New York, Pittsburgh, Scottsdale and Berlin
New York, US (HQ)
430 Park Ave #702
Pittsburgh, US
Carson
Scottsdale, US
E Shea Blvd #100
Show all (4)

RenovaCare Financials and Metrics

RenovaCare Revenue

RenovaCare's revenue was reported to be $19.49 k in FY, 2012
USD

Net income (Q1, 2020)

(1.2m)

EBIT (Q1, 2020)

(1.2m)

Market capitalization (9-Jul-2020)

192.2m

Closing stock price (9-Jul-2020)

2.2

Cash (31-Mar-2020)

11.4m
RenovaCare's current market capitalization is $192.2 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

32.8k19.5k

Cost of goods sold

20.6k

Gross profit

(1.1k)

Gross profit Margin, %

(6%)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

10.1k6.1k6.1k3.5k7.0k

General and administrative expense

132.1k152.0k80.8k69.1k38.1k70.4k83.4k184.9k268.0k333.7k373.6k203.8k165.7k216.4k669.1k453.5k223.8k303.0k861.4k434.9k449.6k341.2k386.8k409.5k464.3k1.1m1.0m

R&D expense

101.9k39.8k3.1k8.1k902.2k61.4k50.2k80.7k111.8k73.8k45.4k79.1k144.9k139.8k125.1k108.2k45.7k194.5k179.2k130.5k192.8k

Operating expense total

234.0k191.8k84.0k77.3k38.1k70.4k83.4k184.9k268.0k333.7k1.3m265.2k215.9k297.0k780.9k527.4k269.2k382.1k1.0m574.7k574.7k449.4k432.5k604.0k643.5k1.2m1.2m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

787.8k513.6k1.5m683.1k397.6k418.0k2.9m15.4m12.2m

Accounts Receivable

14.5k800.080.0k

Prepaid Expenses

7.6k1.2k7.4k10.3k750.0168.7k102.5k

Current Assets

802.3k522.0k1.5m690.5k407.9k449.6k2.9m15.6m12.3m
USDQ2, 2011

Financial Leverage

-2.7 x
Show all financial metrics

RenovaCare Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

RenovaCare Online and Social Media Presence

Embed Graph

RenovaCare News and Updates

RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services

ROSELAND, N.J., June 10, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the appointment of its first Chief Medical Of…

RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer

ROSELAND, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that its Vice President, Scientific Affairs, D…

Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London

ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company’s novel SkinGun™ is now bei…

RenovaCare Stockholder Update and 2020 Outlook from the CEO

SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, is pleased to provide this update from its new CEO, Mr. Alan L. Rubino, as well a…

Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare

SCOTTSDALE, Ariz., July 11, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment of Dr. Ben Walthall to the Comp…

RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing

SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ and other patented technologies for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment…
Show more

RenovaCare Blogs

RenovaCare Appoints Alan L. Rubino as President and CEO

Scottsdale, AZ – November 18, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of  Alan L. Rubino as President and Chief Executive Officer…

Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare

Scottsdale, AZ – September 24th, 2019 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Frank Gerberick to its Board of Advisors t…

Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare

Scottsdale, AZ – August 20th, 2019 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of its Vice President of Scientific Affairs, Dr. Rob…

RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues

Scottsdale, AZ – August 14, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Compan…

Former Johnson & Johnson Worldwide Director For Advanced Wound Care Joins RenovaCare

Scottsdale, AZ – July 11, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment of Dr. Ben Walthall to the Company’s Advisory Board.

RenovaCare Chairman Invests $15.5 Million to Fund SkinGun Regulatory Submissions and Clinical Trials

Scottsdale, AZ– November 29th, 2018 - RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation,…
Show more

RenovaCare Frequently Asked Questions

  • Who are RenovaCare key executives?

    RenovaCare's key executives are Harmel S. Rayat, Kenneth Kirkland and Alan L. Rubino.

  • How many employees does RenovaCare have?

    RenovaCare has 1 employees.

  • Who are RenovaCare competitors?

    Competitors of RenovaCare include Reich, Ortosintese and Ote Pharma.

  • Where is RenovaCare headquarters?

    RenovaCare headquarters is located at 430 Park Ave #702, New York.

  • Where are RenovaCare offices?

    RenovaCare has offices in New York, Pittsburgh, Scottsdale and Berlin.

  • How many offices does RenovaCare have?

    RenovaCare has 4 offices.